课题基金 / 基金详情

项目摘要

项目成果

Michael A Portman的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(申请人提供):STAR计划于2014年完成其第五年的资助,我们正在重新提交赠款以供考虑。该计划在有效培训代表不足的少数族裔、第一代、经济困难和残疾学生追求健康、生物医学和生物行为研究道路方面发挥了不可或缺的作用。该计划未来五年的长期目标是扩大其计划,将参与者人数从71%增加到75%,进入并完成生物医学和行为专业,并最终进入专业/研究生课程。为了实现这一目标,华盛顿大学STAR项目团队建议将一系列扩大的活动和一个由教职员工组成的协作团队结合在一起,以实施其倡议。在继续加强学生的学术和技术技能的同时,该计划还将专注于帮助参与者了解与心脏、肺和血液相关的研究的作用,以及这项研究在解决代表性不足社区的健康差距方面的后续影响。(摘要结束)
英文摘要
 DESCRIPTION (provided by applicant): The STAR Program completed its fifth year of funding in 2014 and we are resubmitting the grant for consideration. The Program has been an integral contributor in effectively training underrepresented minority, first generation, economically disadvantaged, and disabled students to pursue health, biomedical, and biobehavioral research pathways. The long-term objective of the Program's next five years is to expand its initiatives to increase from 71% to 75% the number of participants, entering and completing biomedical and behavioral majors and eventually matriculating into professional/graduate programs. To fulfill this objective, the UW STAR Program team proposes to bring together an expanded set of activities and a collaborative team of faculty and staff to implement its initiative. While continung to strengthen students' academic and technical skills, the Program will also focus on helping participants understand the role of heart, lung, and blood-related research and the subsequent impact of this research in addressing health disparities in underrepresented communities. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10311527
  • 项目类别:
  • 资助金额:
    $87.05万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10065014
  • 项目类别:
  • 资助金额:
    $84.7万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10517919
  • 项目类别:
  • 资助金额:
    $10.7万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
  • 批准号:
    8610834
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2014
  • 负责人:
    Michael A Portman
  • 依托单位:
海外基金